Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of ORIC Pharmaceuticals patents

List of ORIC Pharmaceuticals patents

List of Powdermet, Inc. patents

List of Axolabs GmbH patents

List of Eos Energy Storage patents

List of companies in Finnovista's investment portfolio

CEOs of breast cancer companies

Patents where

Current Assignee

Name

is

ORIC Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11530236 CD73 inhibitors	Patent 11530236 was granted and assigned to ORIC Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11530236	December 20, 2022
	‌ US Patent 11028120 CD73 inhibitors	Patent 11028120 was granted and assigned to ORIC Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11028120	June 8, 2021
	‌ US Patent 11130778 CD73 inhibitors	Patent 11130778 was granted and assigned to ORIC Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11130778	September 28, 2021
	‌ US Patent 11325938 CD73 inhibitors	Patent 11325938 was granted and assigned to ORIC Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11325938	May 10, 2022
	‌ US Patent 11377469 CD73 inhibitors	Patent 11377469 was granted and assigned to ORIC Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11377469	July 5, 2022
	‌ US Patent 11129841 CD73 inhibitors	Patent 11129841 was granted and assigned to ORIC Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11129841	September 28, 2021
	‌ US Patent 11576922 CD73 inhibitors	Patent 11576922 was granted and assigned to ORIC Pharmaceuticals on February, 2023 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11576922	February 14, 2023
	‌ US Patent 11208432 Inhibitors of glucocorticoid receptor	Patent 11208432 was granted and assigned to ORIC Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11208432	December 28, 2021
	‌ US Patent 11124537 Inhibitors of glucocorticoid receptor	Patent 11124537 was granted and assigned to ORIC Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11124537	September 21, 2021
	‌ US Patent 10472387 Inhibitors of glucocorticoid receptor	Patent 10472387 was granted and assigned to ORIC Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	10472387	November 12, 2019
	‌ US Patent 10836789 Inhibitors of glucocorticoid receptor	Patent 10836789 was granted and assigned to ORIC Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	10836789	November 17, 2020
	‌ US Patent 10723759 Inhibitors of glucocorticoid receptor	Patent 10723759 was granted and assigned to ORIC Pharmaceuticals on July, 2020 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	10723759	July 28, 2020
	‌ US Patent 11110103 Inhibitors of glucocorticoid receptor	Patent 11110103 was granted and assigned to ORIC Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11110103	September 7, 2021
	‌ US Patent 12018043 CD73 inhibitors	Patent 12018043 was granted and assigned to ORIC Pharmaceuticals on June, 2024 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	12018043	June 25, 2024
	‌ US Patent 11858915 Polo like kinase 4 inhibitors	Patent 11858915 was granted and assigned to ORIC Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.	ORIC Pharmaceuticals	ORIC Pharmaceuticals		United States Patent and Trademark Office	11858915	January 2, 2024

15 results

0 selected

15 results

0 selected